Rocket Pharmaceuticals (RCKT) Shares Issued (2014 - 2026)

Rocket Pharmaceuticals (RCKT) has 13 years of Shares Issued data on file, last reported at $10.0 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Issued fell 27.78% year-over-year to $10.0 million; the trailing twelve-month figure through Mar 2026 stood at $10.0 million (down 27.78% YoY), and the FY2025 full-year result was $12.2 million, down 24.19% from the prior year.
• Shares Issued slipped to $10.0 million in Q1 2026, from $12.2 million in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $16.1 million in Q3 2024 to a low of $9.1 million in Q1 2022.
• A 5-year average of $13.0 million and a median of $13.1 million in 2022 frame the typical range for Shares Issued.
• Across the five-year window, Shares Issued soared 60.28% in 2023 and decreased 27.78% in 2026, its largest moves.
• Tracing RCKT's Shares Issued over 5 years: stood at $13.1 million in 2022, then grew by 13.13% to $14.9 million in 2023, then gained by 7.94% to $16.0 million in 2024, then decreased by 24.19% to $12.2 million in 2025, then retreated by 17.63% to $10.0 million in 2026.
• Business Quant data shows RCKT's Shares Issued at $10.0 million in Q1 2026, $12.2 million in Q4 2025, and $13.8 million in Q3 2025.